China’s biopharmaceutical sector is showing signs of revival from its post-pandemic slump, even as its US counterpart remains ...

Fresh off a splashy obesity deal, Zealand Pharma is doubling down on its R&D ambitions with a new chief scientific officer.

Telenutrition platform Nourish has raised $70 million and reached profitability a little more than a year after its last ...

Summit Therapeutics and Akeso said their PD-1xVEGF bispecific antibody ivonescimab beat BeiGene’s PD-1 blocker Tevimbra in a ...

Repertoire Immune Medicines makes a major announcement in April. And this year is no different. The Flagship ...

A small Northwestern University spinout attempting to develop a twist on biologics has pulled together a $30 million Series A ...

Eli Lilly on Thursday filed lawsuits against four telehealth companies over their sale of compounded versions of the GLP-1 ...

Boehringer Ingelheim has inked a research collaboration with Tessellate Bio to develop precision medicines for cancers that ...

The FDA has asked Novavax to commit to producing post-marketing data of its Covid vaccine, the clearest example yet that the bar is higher for advancing new vaccines under HHS Secretary Robert F.

A Bay Area protein design startup wants to build more potent antibody-drug conjugates, and is starting with $20 million in seed funding. The company, Synthetic Design Lab, was founded by ...

Fujifilm Diosynth Biotechnologies' bet on its North Carolina biologics facility is paying off, as Regeneron plans to shell ...

British drugmaker AstraZeneca is rejoining the drug industry's major US lobbying group, PhRMA, roughly two years after ...